vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Katapult Holdings, Inc. (KPLT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $73.9M, roughly 1.2× Katapult Holdings, Inc.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs 22.8%, a 4.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 17.3%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-12.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.6%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.

FDMT vs KPLT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.2× larger
FDMT
$85.1M
$73.9M
KPLT
Growing faster (revenue YoY)
FDMT
FDMT
+8508882.7% gap
FDMT
8508900.0%
17.3%
KPLT
Higher net margin
KPLT
KPLT
4.1% more per $
KPLT
26.8%
22.8%
FDMT
More free cash flow
FDMT
FDMT
$40.4M more FCF
FDMT
$28.5M
$-12.0M
KPLT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
6.6%
KPLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
KPLT
KPLT
Revenue
$85.1M
$73.9M
Net Profit
$19.4M
$19.8M
Gross Margin
15.6%
Operating Margin
17.3%
-1.4%
Net Margin
22.8%
26.8%
Revenue YoY
8508900.0%
17.3%
Net Profit YoY
139.1%
307.3%
EPS (diluted)
$0.43
$3.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
KPLT
KPLT
Q4 25
$85.1M
$73.9M
Q3 25
$90.0K
$74.0M
Q2 25
$15.0K
$71.9M
Q1 25
$14.0K
$71.9M
Q4 24
$1.0K
$63.0M
Q3 24
$3.0K
$60.3M
Q2 24
$5.0K
$58.9M
Q1 24
$28.0K
$65.1M
Net Profit
FDMT
FDMT
KPLT
KPLT
Q4 25
$19.4M
$19.8M
Q3 25
$-56.9M
$-4.9M
Q2 25
$-54.7M
$-7.8M
Q1 25
$-48.0M
$-5.7M
Q4 24
$-9.6M
Q3 24
$-43.8M
$-8.9M
Q2 24
$-35.0M
$-6.9M
Q1 24
$-32.4M
$-570.0K
Gross Margin
FDMT
FDMT
KPLT
KPLT
Q4 25
15.6%
Q3 25
19.7%
Q2 25
15.5%
Q1 25
19.9%
Q4 24
11.8%
Q3 24
19.8%
Q2 24
16.9%
Q1 24
25.3%
Operating Margin
FDMT
FDMT
KPLT
KPLT
Q4 25
17.3%
-1.4%
Q3 25
-67983.3%
3.3%
Q2 25
-396373.3%
-2.0%
Q1 25
-383007.1%
-0.7%
Q4 24
-7.7%
Q3 24
-1704400.0%
-7.4%
Q2 24
-849120.0%
-4.5%
Q1 24
-136200.0%
5.8%
Net Margin
FDMT
FDMT
KPLT
KPLT
Q4 25
22.8%
26.8%
Q3 25
-63195.6%
-6.7%
Q2 25
-364386.7%
-10.9%
Q1 25
-342657.1%
-7.9%
Q4 24
-15.2%
Q3 24
-1461433.3%
-14.7%
Q2 24
-699060.0%
-11.7%
Q1 24
-115717.9%
-0.9%
EPS (diluted)
FDMT
FDMT
KPLT
KPLT
Q4 25
$0.43
$3.69
Q3 25
$-1.01
$-0.94
Q2 25
$-0.98
$-1.63
Q1 25
$-0.86
$-1.23
Q4 24
$-2.17
Q3 24
$-0.79
$-2.05
Q2 24
$-0.63
$-1.61
Q1 24
$-0.66
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
KPLT
KPLT
Cash + ST InvestmentsLiquidity on hand
$402.7M
$22.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$-38.1M
Total Assets
$566.7M
$107.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
KPLT
KPLT
Q4 25
$402.7M
$22.4M
Q3 25
$305.1M
$3.4M
Q2 25
$293.2M
$3.7M
Q1 25
$321.4M
$6.0M
Q4 24
$424.9M
$3.5M
Q3 24
$501.9M
$25.9M
Q2 24
$541.9M
$33.7M
Q1 24
$525.9M
$31.2M
Stockholders' Equity
FDMT
FDMT
KPLT
KPLT
Q4 25
$505.7M
$-38.1M
Q3 25
$369.0M
$-58.4M
Q2 25
$420.9M
$-54.1M
Q1 25
$469.7M
$-51.7M
Q4 24
$510.6M
$-46.8M
Q3 24
$552.9M
$-40.3M
Q2 24
$588.3M
$-32.9M
Q1 24
$600.6M
$-27.5M
Total Assets
FDMT
FDMT
KPLT
KPLT
Q4 25
$566.7M
$107.9M
Q3 25
$424.0M
$85.9M
Q2 25
$473.6M
$90.6M
Q1 25
$515.7M
$88.5M
Q4 24
$560.4M
$93.2M
Q3 24
$604.0M
$92.0M
Q2 24
$620.1M
$106.6M
Q1 24
$629.9M
$106.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
KPLT
KPLT
Operating Cash FlowLast quarter
$28.6M
$-11.9M
Free Cash FlowOCF − Capex
$28.5M
$-12.0M
FCF MarginFCF / Revenue
33.5%
-16.2%
Capex IntensityCapex / Revenue
0.1%
0.0%
Cash ConversionOCF / Net Profit
1.47×
-0.60×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
KPLT
KPLT
Q4 25
$28.6M
$-11.9M
Q3 25
$-46.5M
$4.0M
Q2 25
$-43.4M
$-6.6M
Q1 25
$-47.8M
$3.4M
Q4 24
$-134.6M
$-32.6M
Q3 24
$-29.4M
$-5.4M
Q2 24
$-30.2M
$-628.0K
Q1 24
$-29.1M
$2.0M
Free Cash Flow
FDMT
FDMT
KPLT
KPLT
Q4 25
$28.5M
$-12.0M
Q3 25
$-46.6M
$4.0M
Q2 25
$-43.4M
Q1 25
$-48.4M
$3.4M
Q4 24
$-138.4M
$-32.6M
Q3 24
$-31.2M
$-5.4M
Q2 24
$-30.6M
$-653.0K
Q1 24
$-29.8M
FCF Margin
FDMT
FDMT
KPLT
KPLT
Q4 25
33.5%
-16.2%
Q3 25
-51765.6%
5.4%
Q2 25
-289620.0%
Q1 25
-345635.7%
4.7%
Q4 24
-13837100.0%
-51.8%
Q3 24
-1038966.7%
-9.0%
Q2 24
-611840.0%
-1.1%
Q1 24
-106421.4%
Capex Intensity
FDMT
FDMT
KPLT
KPLT
Q4 25
0.1%
0.0%
Q3 25
101.1%
0.0%
Q2 25
440.0%
0.0%
Q1 25
4507.1%
0.0%
Q4 24
378600.0%
0.1%
Q3 24
59266.7%
0.0%
Q2 24
6980.0%
0.0%
Q1 24
2535.7%
0.0%
Cash Conversion
FDMT
FDMT
KPLT
KPLT
Q4 25
1.47×
-0.60×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons